Dr Chee Chun Tan, MD in Neptune, NJ - Medicare Pediatrics

Dr Chee Chun Tan, MD is a medicare enrolled "Pediatrics - Pediatric Pulmonology" physician in Neptune, New Jersey. His current practice location is 19 Davis Ave Fl 5, Neptune, New Jersey. You can reach out to his office (for appointments etc.) via phone at (732) 776-4268.

Dr Chee Chun Tan is licensed to practice in New Jersey (license number 25MA10894600) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1114185915.

Contact Information

	Dr Chee Chun Tan, MD
	19 Davis Ave Fl 5, Neptune, NJ 07753-4488
	(732) 776-4268
	(732) 776-3178

Physician's Profile

Full Name	Dr Chee Chun Tan
Gender	Male
Speciality	Pediatrics - Pediatric Pulmonology
Location	19 Davis Ave Fl 5, Neptune, New Jersey
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1114185915
Provider Enumeration Date: 05/28/2008
Last Update Date: 05/13/2022

Medicare PECOS Information:

PECOS PAC ID: 9234379595
Enrollment ID: I20130709000796

Medical Identifiers

Medical identifiers for Dr Chee Chun Tan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114185915	NPI	-	NPPES
0751715	Medicaid	NJ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2080P0214X	Pediatrics - Pediatric Pulmonology	25MA10894600 (New Jersey)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Chee Chun Tan allows following entities to bill medicare on his behalf.

Entity Name	Ihc Health Services Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079

News Archive

Imagexpres inks distributor/supply agreement with Dalton Corporation

ImageXpres Corporation, today announced it has signed a Distributor/Supply Agreement with Dalton Corporation, a Taiwan-based manufacturer of digital hardware and software products, that are sold throughout the world, including private label for well-known brands.

Seven percent of college students have used prescription stimulants for non-medical purposes

Seven percent of college students have used prescription stimulants for non-medical purposes over their lifetimes and 4 percent have used in the past year, according to a study of students at 119 four-year colleges and universities nationwide published in the January issue of the journal Addiction.

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

AbbVie, a global biopharmaceutical company, today announced that a Phase 2 trial of its investigational medicine venetoclax met its primary endpoint of achieving overall response rates in patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia (CLL) with 17p deletion, according to an independent review analysis.

Researchers highlight the need to renew understanding of adverse events in interventional radiology

Medical errors pose a serious threat to patient safety and are estimated to account for more than 250,000 deaths in the U.S. each year.

Cordis announces launch of ExoSeal Vascular Closure Device

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced the launch of the ExoSeal(TM) Vascular Closure Device. ExoSeal(TM) incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure. Cordis Corporation received CE-Marking approval for ExoSeal(TM) Vascular Closure Device in May 2010.

Entity Name	Pediatric Pulmonology Department Of University Of Utah
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1255428314 PECOS PAC ID: 9931142460 Enrollment ID: O20050606001176

Imagexpres inks distributor/supply agreement with Dalton Corporation

Seven percent of college students have used prescription stimulants for non-medical purposes

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Researchers highlight the need to renew understanding of adverse events in interventional radiology

Medical errors pose a serious threat to patient safety and are estimated to account for more than 250,000 deaths in the U.S. each year.

Cordis announces launch of ExoSeal Vascular Closure Device

Entity Name	University Of Utah Pediatric Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1487018974 PECOS PAC ID: 0547552473 Enrollment ID: O20160713000371

Imagexpres inks distributor/supply agreement with Dalton Corporation

Seven percent of college students have used prescription stimulants for non-medical purposes

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Researchers highlight the need to renew understanding of adverse events in interventional radiology

Medical errors pose a serious threat to patient safety and are estimated to account for more than 250,000 deaths in the U.S. each year.

Cordis announces launch of ExoSeal Vascular Closure Device

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Chee Chun Tan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Chee Chun Tan, MD 19 Davis Ave Fl 5, Neptune, NJ 07753-4488 Ph: (732) 776-4268	Dr Chee Chun Tan, MD 19 Davis Ave Fl 5, Neptune, NJ 07753-4488 Ph: (732) 776-4268

News Archive

Imagexpres inks distributor/supply agreement with Dalton Corporation

Seven percent of college students have used prescription stimulants for non-medical purposes

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Researchers highlight the need to renew understanding of adverse events in interventional radiology

Medical errors pose a serious threat to patient safety and are estimated to account for more than 250,000 deaths in the U.S. each year.

Cordis announces launch of ExoSeal Vascular Closure Device

Pediatrics Doctors in Neptune, NJ

Helen Karwowska, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 19 Davis Ave Fl 7, Neptune, NJ 07753 Phone: 732-776-4524 Fax: 732-776-4639
Beth Ann Loveridge-lenza, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 61 Davis Ave, Neptune, NJ 07753 Phone: 732-776-4860 Fax: 732-776-3509
Dr. Ann S Ross, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 19 Davis Ave Fl 7, Neptune, NJ 07753 Phone: 732-776-4524 Fax: 732-776-4639
Dr. Jennifer Jimenez, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 61 Davis Ave, Suite 1, Neptune, NJ 07753 Phone: 732-776-4860 Fax: 732-776-4867
Blair Faith Germain, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 19 Davis Ave Fl 7, Neptune, NJ 07753 Phone: 732-776-4524 Fax: 732-776-4639
Dr. Heather Grossman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 19 Davis Ave Fl 5, Neptune, NJ 07753 Phone: 732-776-3892
Thomas Patrick Fitzgerald, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1945 State Route 33, Neptune, NJ 07754 Phone: 732-776-4483 Fax: 732-776-4798

Dr Chee Chun Tan, MD - Medicare Pediatrics in Neptune, NJ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Imagexpres inks distributor/supply agreement with Dalton Corporation

Seven percent of college students have used prescription stimulants for non-medical purposes

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Researchers highlight the need to renew understanding of adverse events in interventional radiology

Cordis announces launch of ExoSeal Vascular Closure Device

Imagexpres inks distributor/supply agreement with Dalton Corporation

Seven percent of college students have used prescription stimulants for non-medical purposes

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Researchers highlight the need to renew understanding of adverse events in interventional radiology

Cordis announces launch of ExoSeal Vascular Closure Device

Imagexpres inks distributor/supply agreement with Dalton Corporation

Seven percent of college students have used prescription stimulants for non-medical purposes

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Researchers highlight the need to renew understanding of adverse events in interventional radiology

Cordis announces launch of ExoSeal Vascular Closure Device

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Imagexpres inks distributor/supply agreement with Dalton Corporation

Seven percent of college students have used prescription stimulants for non-medical purposes

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Researchers highlight the need to renew understanding of adverse events in interventional radiology

Cordis announces launch of ExoSeal Vascular Closure Device

Pediatrics Doctors in Neptune, NJ